| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000011687 |
| Receipt No. | R000013662 |
| Official scientific title of the study | A feasibility study of short hydration regimen for lung cancer patients receiving cisplatin-based chemotherapy |
| Date of disclosure of the study information | 2013/10/01 |
| Last modified on | 2016/09/12 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | A feasibility study of short hydration regimen for lung cancer patients receiving cisplatin-based chemotherapy | |
| Title of the study (Brief title) | A feasibility study of short hydration regimen for lung cancer patients receiving cisplatin-based chemotherapy | |
| Region |
|
|
| Condition | ||
| Condition | Lung cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | to evaluate the feasibility of short hydration of cisplatin-based chemotherapy for lung cancer patients |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | proportion of the patients without grade 2 to 4 creatinine elevation based on NCI-CTCAE ver4.0 |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | short hydration | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)patients with pathologically proven lung cancer
2)patients recieving cisplatin dose of 60mg/m2 or above 3)patients without treatment history of chemotherapy 4)20 years of age or older, 75 years of age or younger 5)appropriate organ function 6)adequate renal function serum creatinine level under 1.5mg/dl creatinine clearance over 60ml/min 7)oxigen saturation on room air over 90% 8)Performance status (ECOG) 0-1 9)written informed consent |
|||
| Key exclusion criteria | 1)active infection
2)pregnant or lactating woman and possibility of the pregnancy in the six months after completion of the study 3)a histroy of a severe drug allergy 4)severe comobidity 5)judged to be inappropriate by the attending doctor |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshinori Hasegawa |
| Organization | Nagoya University graduate scool of medicine |
| Division name | department of respiratory medicine |
| Address | 65 Tsurumai-cho Showa-ku, Nagoya |
| TEL | 052-744-2167 |
| yhasega@med.nagoya-u.ac.jp | |
| Public contact | |
| Name of contact person | Tetsunari Hase |
| Organization | Nagoya University graduate scool of medicine |
| Division name | department of respiratory medicine |
| Address | 65 Tsurumai-cho Showa-ku, Nagoya |
| TEL | 052-744-2167 |
| Homepage URL | |
| thase@med.nagoya-u.ac.jp | |
| Sponsor | |
| Institute | Nagoya University graduate scool of medicine, department of respiratory medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nagoya University graduate scool of medicine, department of respiratory medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000013662 |